StockpollyBeta
Get App
Popularity #3,486
SGHT · NASDAQ · Medical - Devices

Sight Sciences (SGHT)

Develops interventional devices for glaucoma surgery and dry eye treatment.

$8.59
After hours−0.01 (−0.06%)
At close$8.60(+1.24%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue201919212019182020202023
Cost of revenue333333233332
Gross profit171616181717151717181721
312731312828292825212925
Research & development435454443233
272427272324252422192723
Selling & marketing020001000000
General & administrative022000230000023
Operating income−13−11−15−13−11−12−14−12−8−4−12−4
00−20000000−1−1
Interest income000000010100
Interest expense1111111111−11
Other non-operating income−2−20−1−1−1−1−1−1−1−11
Income before tax−13−11−16−12−11−12−14−12−8−4−13−4
Income tax expense000000000000
Net income from continuing operations−13−11−16−12−11−12−14−12−8−4−13−4
Net income−13−11−16−12−11−12−14−12−8−4−13−4
EPS, basic−$0.27−$0.22−$0.33−$0.25−$0.22−$0.23−$0.28−$0.23−$0.16−$0.08−$0.24−$0.08
EPS, diluted−$0.27−$0.22−$0.33−$0.25−$0.22−$0.23−$0.28−$0.23−$0.16−$0.08−$0.24−$0.08
Weighted average shares, basic494949505051515252535455
Weighted average shares, diluted494949505051515252535455
EBITDA−11−9−15−11−10−10−13−10−7−3−12−5
Depreciation & amortization000000000000
EBIT−12−9−15−11−10−11−13−11−7−3−12−5